Literature DB >> 15588513

Enhancement of cell survival by stromal cell-derived factor-1/CXCL12 involves activation of CREB and induction of Mcl-1 and c-Fos in factor-dependent human cell line MO7e.

Eun-Kyoung Joo1, Hal E Broxmeyer, Hyung-Joo Kwon, Ho Bum Kang, Jin Sook Kim, Jong Seok Lim, Yong-Kyoung Choe, In Seong Choe, Pyung Keun Myung, Younghee Lee.   

Abstract

Stromal cell-derived factor-1 (SDF-1/CXCL12) enhances the survival of hematopoietic stem and progenitor cells in synergy with other cytokines such as granulocyte-macrophage colony-stimulating factor (GM-CSF), steel factor, and thrombopoietin (TPO), and both the PI3K/Akt and MAPK pathways have been linked to this survival. To further evaluate intracellular signaling involved in SDF-1/CXCL12 survival effects, we investigated modulation of downstream signaling molecules. The synergistic survival enhancement of SDF-1/CXCL12 plus other cytokines were directly linked to enhanced phosphorylation of p70/85S6K and cAMP responsive element binding protein (CREB), as well as enhanced induction of the Bcl-2 family member Mcl-1. Most prominently, c-Fos, a component of AP1 transcription factor, was synergistically induced by SDF-1/CXCL12 plus other cytokines. These results suggest that SDF-1/CXCL12 enhanced cell survival in synergy with other cytokines involves activation of CREB and induction of Mcl-1 and c-Fos.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15588513     DOI: 10.1089/scd.2004.13.563

Source DB:  PubMed          Journal:  Stem Cells Dev        ISSN: 1547-3287            Impact factor:   3.272


  9 in total

1.  SDF-1/CXCR4 axis modulates bone marrow mesenchymal stem cell apoptosis, migration and cytokine secretion.

Authors:  Xiaolei Liu; Biyan Duan; Zhaokang Cheng; Xiaohua Jia; Lina Mao; Hao Fu; Yongzhe Che; Lailiang Ou; Lin Liu; Deling Kong
Journal:  Protein Cell       Date:  2011-11-06       Impact factor: 14.870

2.  Distinct modifications in Kv2.1 channel via chemokine receptor CXCR4 regulate neuronal survival-death dynamics.

Authors:  Andrew J Shepherd; Lipin Loo; Raeesa P Gupte; Aaron D Mickle; Durga P Mohapatra
Journal:  J Neurosci       Date:  2012-12-05       Impact factor: 6.167

3.  Diverse marrow stromal cells protect CLL cells from spontaneous and drug-induced apoptosis: development of a reliable and reproducible system to assess stromal cell adhesion-mediated drug resistance.

Authors:  Antonina V Kurtova; Kumudha Balakrishnan; Rong Chen; Wei Ding; Susanne Schnabl; Maite P Quiroga; Mariela Sivina; William G Wierda; Zeev Estrov; Michael J Keating; Medhat Shehata; Ulrich Jäger; Varsha Gandhi; Neil E Kay; William Plunkett; Jan A Burger
Journal:  Blood       Date:  2009-09-17       Impact factor: 22.113

4.  SDF-1/CXCL12 modulates mitochondrial respiration of immature blood cells in a bi-phasic manner.

Authors:  Steven Messina-Graham; Hal Broxmeyer
Journal:  Blood Cells Mol Dis       Date:  2016-01-28       Impact factor: 3.039

5.  CCL5-mediated T-cell chemotaxis involves the initiation of mRNA translation through mTOR/4E-BP1.

Authors:  Thomas T Murooka; Ramtin Rahbar; Leonidas C Platanias; Eleanor N Fish
Journal:  Blood       Date:  2008-03-12       Impact factor: 22.113

6.  A naturally occurring splice variant of CXCL12/stromal cell-derived factor 1 is a potent human immunodeficiency virus type 1 inhibitor with weak chemotaxis and cell survival activities.

Authors:  Jeffrey D Altenburg; Hal E Broxmeyer; Qingwen Jin; Scott Cooper; Sunanda Basu; Ghalib Alkhatib
Journal:  J Virol       Date:  2007-05-16       Impact factor: 5.103

7.  Rapid mobilization of murine and human hematopoietic stem and progenitor cells with AMD3100, a CXCR4 antagonist.

Authors:  Hal E Broxmeyer; Christie M Orschell; D Wade Clapp; Giao Hangoc; Scott Cooper; P Artur Plett; W Conrad Liles; Xiaxin Li; Barbara Graham-Evans; Timothy B Campbell; Gary Calandra; Gary Bridger; David C Dale; Edward F Srour
Journal:  J Exp Med       Date:  2005-04-18       Impact factor: 14.307

8.  New mechanistic insights into modifiable risk factors that promote pancreatic cancer.

Authors:  Supriya Srinivasan; Austin R Dosch; Nagaraj S Nagathihalli
Journal:  Oncotarget       Date:  2019-03-29

9.  Contribution of natural inhibitors to the understanding of the PI3K/PDK1/PKB pathway in the insulin-mediated intracellular signaling cascade.

Authors:  Jae Youl Cho; Jongsun Park
Journal:  Int J Mol Sci       Date:  2008-11-12       Impact factor: 6.208

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.